Top segments and regional performance

Last year, the company generated ‪61.52 B‬ CHF, the most of which — ‪49.45 B‬ CHF — came from its top-performing segment, Pharmaceuticals, compared to ‪48.04 B‬ CHF the previous year. The greatest contribution came from United States, which accounted for ‪30.72 B‬ CHF last year, with ‪30.17 B‬ CHF the year before.